Light heavyweight Nick Roehrick entered the UFC on a seven-fight win streak, but lost his short-notice league debut vs. Jared Cannonier via Elbow T/KO in Round 3 at the TUF 25 Finale on July 7. About a month later an anti-doping test administered by USADA the UFC’s selected independent testing agency. The test was later flagged, and Roehrick was provisionally suspended on August 27. Following an investigation, he has now been suspended for a year.

Via ufc.usada.org.

Roehrick, 30, tested positive for clomiphene and its metabolite, 4-hydroxyclomiphene, following an out-of-competition urine test conducted on August 8, 2017. Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.

Clomiphene is not approved by the U.S. Food & Drug Administration (FDA) for use in the male population, meaning such off-label clinical use has not been thoroughly studied for safety and efficacy. Clomiphene also indirectly promotes the secretion of testosterone. Increasing testosterone, especially when combined with strength training, has been demonstrated to increase fat-free mass, muscle size, and strength in males, potentially leading to performance enhancement in sport.

Roehrick’s one-year period of ineligibility, the highest sanction for a first offense involving a Specified Substance, began on August 17, 2017, the date his provisional suspension was imposed.

PEDs remain in the system for varying periods of time, so fighters wanting to get into the UFC should understand that when the call comes, it comes suddenly, as does the testing. So fighters in the UFC can’t dope, but fighters wanting to get into the UFC are also jeopardizing their career.